Clinical Trial Update: Immunotherapy Before and After Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial investigating immunotherapy before and after surgery for high-risk prostate cancer; status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: High-risk Prostate Cancer | Phase 2 | Status: NOT_YET_RECRUITING